ONCOHOST - About the company
ONCOHOST is a series C company based in Binyamina Giv at Ada (Israel), founded in 2017 by Yuval Shaked and Ofer Sharon. It operates as an AI-based oncology therapy plan solution for professionals. ONCOHOST has raised $43M in funding from OurCrowd and ALIVE. The company has 762 active competitors, including 90 funded and 77 that have exited. Its top competitors include companies like Biodesix, Strand Life Sciences and OncoCyte.
Company Details
AI-based oncology therapy plan solution for patients and professionals. The company has developed a proprietary proteomic analysis that can analyze the proteomic changes in the blood sample induced by the patient in response to cancer therapy. The company also provide treatment strategy to improve the effectiveness of therapy. It also provides consultancy services to patients, oncologists, nurses, and pharma companies among others. The company has developed PROphet which is a bioinformatics tool used to identify proteomic patterns related to therapy.
- Website
- www.oncohost.com/
- Phone Number
- +972 **********
Key Metrics
Founded Year
2017
Location
Binyamina Giv at Ada, Israel
Stage
Series C
Total Funding
$43M in 4 rounds
Latest Funding Round
Ranked
7th among 762 active competitors
Employee Count
44 as on Jun 30, 2026
Similar Companies
Sign up to download ONCOHOST's company profile
ONCOHOST's funding and investors
ONCOHOST has raised a total funding of $43M over 4 rounds. Its first funding round was on Jan 21, 2020. Its latest funding round was a Grant (prize money) round on May 15, 2025 for $*****. 1 investor participated in its latest round. ONCOHOST has 7 institutional investors.
Here is the list of recent funding rounds of ONCOHOST:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
May 15, 2025 | 9379325 | Grant (prize money) | 5806051 | 8663079 | 9710262 | 1396736 |
May 10, 2022 | 3923584 | Series C | 1877978 | 5319588 | 1190685 | |
Jan 19, 2021 | 5685055 | Series B | 9754045 | 1722130 | 6864260 |
View details of ONCOHOST's funding rounds and investors
ONCOHOST's founders and board of directors
Founder? Claim ProfileHere are the details of ONCOHOST's key team members:
- Yuval Shaked: Co-Founder of ONCOHOST. Contact Info: 1 email address
- Ofer Sharon: Co-Founder & CEO of ONCOHOST. Contact Info: 1 email address
View details of ONCOHOST's Founder profiles and Board Members
ONCOHOST's employee count trend
ONCOHOST has 44 employees as of Jun 26. Here is ONCOHOST's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
ONCOHOST's Competitors and alternates
Top competitors of ONCOHOST include Biodesix, Strand Life Sciences and OncoCyte. Here is the list of Top 10 competitors of ONCOHOST, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Biodesix 2005, Boulder (United States), Public | Developer of diagnostics assays for the detection of cancer | $200M | 75/100 | |
2nd | Strand Life Sciences 2000, Bengaluru (India), Acquired | Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery | $34.9M | 73/100 | |
3rd | OncoCyte 2009, Irvine (United States), Public | Developer of non-invasive diagnostic tests solutions for the treatment of cancer | $15.3M | 66/100 | |
4th | Provider of services in genome sequencing | - | 64/100 | ||
5th | Hexagon Bio 2017, Menlo Park (United States), Series B | Provider of bioinformatics tools for the analysis of microbial genomic sequencing data | $206M | 63/100 | |
6th | VieCure 2015, Greenwood Village (United States), Series C | AI-based platform for generating oncology treatment plans | $113M | 63/100 | |
7th | AI-based oncology therapy plan solution for professionals | $43M | 60/100 | ||
8th | Oxford Cancer Analytics 2018, Oxford (United Kingdom), Series A | Provider of a platform for detection of lung cancer | $16.5M | 60/100 | |
9th | BostonGene 2015, Waltham (United States), Series B | Developer of cloud-based information and analytics platform to treat cancer | $200M | 57/100 | |
10th | Providing personalised cancer treatment solutions based on patients genomic profile | $128M | 57/100 |
Looking for more details on ONCOHOST's competitors? Click here to see the top ones
ONCOHOST's Investments and acquisitions
ONCOHOST has made no investments or acquisitions yet.
News related to ONCOHOST
Media has covered ONCOHOST for a total of 2 events in the last 1 year.
•
•
OncoHost wins Gold in 2025 Merit Awards for Business in Research and DevelopmentEuropean Pharmaceutical Manufacturer•Jul 10, 2025•ONCOHOST
•
•
•
•
OncoHost partners with Gustave Roussy Cancer InstituteEuropean Pharmaceutical Manufacturer•Mar 03, 2025•ONCOHOST, Gustave Roussy
•
OncoHost Announces Three Abstracts Selected for Presentation at WCLC 2024PR Newswire•Aug 14, 2024•ONCOHOST
•
Dana-Farber Cancer Institute and OncoHost partner for renal cell carcinoma researchPharmaTimes•Jun 10, 2024•ONCOHOST, Dana Farber
•
OncoHost and Dana-Farber Partner on Kidney Cancer (RCC) Biomarker StudyHIT Consultant•Jun 04, 2024•ONCOHOST, Dana Farber
•
OncoHost Launches PROphet® NSCLC Cancer Test in the United StatesTullahoma News•Feb 01, 2023•ONCOHOST
Are you a Founder ?
FAQs about ONCOHOST
Explore our recently published companies
- Sv-Brachthausen-Wirme - Germany based, Unfunded company
- Boltonanddistrictridingclub - United Kingdom based, Unfunded company
- Elements Fitness & Wellbeing - United Kingdom based, 2020 founded, Unfunded company
- Challengealaska - Funding Raised company
- Garsonsgroup - United Kingdom based, Unfunded company
- Ashteadfc - United Kingdom based, Unfunded company